Role of the PBM In a Post-Medicare Reform World

Slides:



Advertisements
Similar presentations
THE COMMONWEALTH FUND Figure 1. Priorities for Improving Health Care Source: Commonwealth Fund Health Care Opinion Leaders Survey, December “President-elect.
Advertisements

PRESENTATION TO ASPECT NOVEMBER 8, EPBC Introduction Launched April 2, WorkBC Employment Services Centres (ESCs) in communities across the.
MEDICARE: PAST, PRESENT AND FUTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
Health Reform: What It Means to Our Community. Health Reform: Key Provisions o Provides coverage to 32 million uninsured people by o Changes insurance.
Purchasers MGMT E 5520 Brenna Baccaro Healthcare System Stakeholders Presentation.
MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.
World Health Organization & World Trade Organization Secretariats.
 The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27,
Heath Lambert Group Insurance and Broking Whither or Wither?
Senen Bacani.  Higher incomes and changing lifestyles will drive the production of premium products conveniently and attractively packaged  Critical.
CONFIDENTIAL – NOT FOR DISTRIBUTION The Manning & Napier Fund, Inc. is managed by Manning & Napier Advisors, LLC (“Manning & Napier”). Manning & Napier.
Title text here Consumer Perspective on Containing Drug Costs Leigh Purvis, Director, Health Services Research.
THE COMMONWEALTH FUND Figure 1. Medicare’s Success in Achieving Major Goals “How successful has Medicare been in accomplishing each of the following specific.
Ed Feaver Prescription Solutions President & CEO.…a health and consumer services company making people’s lives better Pharmacy Management: Prescription.
Benefit Design in Health Care Reform Paul B. Ginsburg, Ph.D. Alliance for Health Reform, Congressional Health Care Reform Educational Project, October.
Layoff Aversion: A Necessary Business Engagement Element Rob Gamble Jeff Ryan #SyncUp.
 2003 Medco Health Solutions, Inc. Implications of the New Medicare Prescription Drug Legislation for Pharmaceutical Manufacturers, PBMs and Health Plans.
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
© 2004 Moses & Singer LLP HIPAA and Patient Privacy Issues Raised by the New Medicare Prescription Drug Program National Medicare Prescription Drug Congress.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Aetna Inc. Smarter is Aetna’s retiree solutions. © 2011 Aetna Inc. XX.XX.XXX.X Month XX, 2011 Presenter Name.
Prepared for: Industry / Agency Relationships February 2015 Panel discussion with Industry participants.
Avalere Health LLC | The intersection of business strategy and public policy The Impact of Enrollment in the Medicare Prescription Drug Benefit on Premiums.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Medicaid Influence in the Drug Market Dana Costea PhD student, Department of Economics, Lehigh University Franklin Carter Assistant Professor, Marketing.
Scottish Employability Services Support
Chapter 8 Strategy in the Global Environment
Health Reform: What It Means to Our Community
Crowe & Associates Lowering Employers’ Insurance Cost With Medicare
Medicaid Coverage of Pharmaceuticals Life Science Tennessee
Key Considerations Presentation will focus on 5 key considerations of the Affordable Care Act (ACA) Incentive to Offer Coverage Regulatory Changes to Large.
Lesson 6-2 Protecting Income
Medicare and Medicaid Week 3.
Started Business 1971 Nations Largest Privately Held Agency Catering to Retiree’s Needs.
November 1, 2005 Cara M. Jareb, FSA
Maryland Healthy Transition Initiative
New Year New Funding New Year New ways of working New Plans New Strategy.
Missouri Behavioral Health Independent Practice Association (IPA)
National Medicare Prescription Drug Congress
Maggie Rafalowicz 28 September 2012
Change Agents Why your Transformational IT Initiative Will Fail Without Them Terri Campbell Sr. Director of Change Leadership.
HCS 490 TUTORS Lessons in Excellence -- hcs490tutors.com.
What does it look like for Property and Casualty Agencies to Partner with Highland? Revised 6/30/16 HCB00478.
Medicare Prescription Drugs Improvement and Modernization Act of 2003:
Networks and/or Provider-based care Financial Performance
The Third National Medicare Congress David B. Snow, Jr.
Lauren Geyer Barnes Avalere Health LLC
Part D Plan Perspective on Serving Dual Eligibles
Mental Health and SUD: Opportunities in Health Reform
Engaging Institutional Leadership
The Role of the Private Sector in Part D
Understanding Medicare
SOUTH AFRICAN INSURANCE ASSOCIATION
Medicare Part D Benefit: A Primer
Prescription drug prices: Recent trends and opportunities for change
Bundled Payments Health Care Industry Committee
Medicare Rx Legislation: Implications for PBMs
Chapter 9: Setting the list or quoted price
Will PBMs Participate in the New Medicare Prescription Drug Program
Pharmacy – Fully Insured versus Self Funding
LEVERAGING PURCHASED/REFERRED CARE (PRC) RATES
State of the pharmacy market
Presented by Tricia Neuman, Sc.D.
Health Reform: What It Means to Our Community
Figure 1. Three of Five Health Care Opinion Leaders Feel that Mixed Private-Public Group Insurance Is an Effective Approach to Achieving Universal Health.
Medicare Reform: Implications for Pharmaceutical Manufacturers
Health Reimbursement Accounts (HRA)
Long Term Care Protection Strategies
A Comfortable Retirement Life Style
Presentation transcript:

Role of the PBM In a Post-Medicare Reform World Brian D. Glassman Prime Therapeutics, LLC February 27, 2004

Medicare Reform and the PBM R O L E O F T H E P B M Medicare Reform and the PBM Discussion Topics: The impact extends beyond Medicare Lessons learned from the endorsed discount card process Defining value in a skeptical and complicated market

The Impact Beyond Medicare

Medicare reform will impact the entire prescription drug market B E Y O N D M E D I C A R E Medicare reform will impact the entire prescription drug market HRAs will accelerate employer movement to defined contribution for all business Potential CMS involvement will set the rules of engagement for the entire market Incentives for the market to move towards M+C will increase the leverage of the big managed care players

For the PBM industry, Medicare will accelerate market movement B E Y O N D M E D I C A R E For the PBM industry, Medicare will accelerate market movement Emphasis on cost control as business moves toward commodity pricing Expansion into non-traditional services to differentiate products Market responses to meet the needs of specific market constituencies Accountability and reporting requirements will change how business is conducted across all segments Increasingly complex business with decreasing margins

Medicare drug reform impacts many types of organizations B E Y O N D M E D I C A R E Medicare drug reform impacts many types of organizations Employer groups Health care plans/M+C players State Medicaid programs Pharmaceutical companies CMS And, of course, PBMs

B E Y O N D M E D I C A R E End users include constituents who may or may not already have drug coverage Group retirees Individual Medigap purchasers M+C beneficiaries Medicare disabled Within these groups there are various sub-segments with different needs e.g., new retirees will have different needs than older retirees

Many are critical of the role PBMs play in the equation B E Y O N D M E D I C A R E Many are critical of the role PBMs play in the equation What value do PBMs add? Does PBM involvement decrease the effectiveness of the entire program by not allowing CMS to negotiate?

PBMs will have to prove they add value to stay relevant B E Y O N D M E D I C A R E PBMs will have to prove they add value to stay relevant Establish a culture of business partner or consultant to help navigate this brave new world Be a valued partner to CMS Demonstrate value If PBMs do not demonstrate value, there is the risk of being locked out, which will impact how the entire market views the PBM industry

Medicare drug reform is complicated, scaring many of its stake holders B E Y O N D M E D I C A R E Medicare drug reform is complicated, scaring many of its stake holders Sprint to the endorsed discount program Part D requires a full-risk solution Sense that this will be huge, but not sure of how Many remaining questions such as actuarial equivalents and specialty pharmacy The only constant is that it will change

Lessons Learned

The endorsed discount program L E S S O N S L E A R N E D The endorsed discount program CMS is still learning about the drug business and is seeking industry input The rules favor M+C plans, but 93 percent of beneficiaries are not in M+C The rule making has been complicated and cumbersome

Home Delivery Businesses L E S S O N S L E A R N E D However, many organizations still came to the table to protect their interests PBMs & Health Plans BCBS/AARP Medicare Part D Home Delivery Businesses Manufacturers

Observations about the Medicare Transitional Assistance program L E S S O N S L E A R N E D Observations about the Medicare Transitional Assistance program From a policy perspective, the Transitional Assistance program is Medicare’s first venture into a funded Rx benefit CMS used the requirements for Transitional Assistance to create a Part D infrastructure prototype With rebates, the economics allowed players to break-even and potentially make money Huge potential market in some states, since the requirements measure income, but not assets

The discount process offered a paradigm for PBMs considering Part D L E S S O N S L E A R N E D The discount process offered a paradigm for PBMs considering Part D PBMs performed/sponsored analysis and created the deal Offered a turnkey solution where the economics created an incentive for sponsors to play PBM as prime contractor, with sponsors private labeling as subcontractors

Range of Part D options for the PBM industry L E S S O N S L E A R N E D Range of Part D options for the PBM industry Sit out Back Room (Traditional Role) Partner/ Consultant Risk Bearing Entity

For the PBM to play in Medicare Part D L E S S O N S L E A R N E D For the PBM to play in Medicare Part D The traditional back room role will not work for most of the market because the stakes are much higher There will be an exception for larger and sophisticated M+C Plans The discount customers can form the base for business partners, but there will be a shake-out In terms of sponsors and PBMs

Defining Value

D E F I N I N G V A L U E The first step will be to lead clients through the legislation and rule making Decode Part D and communicate it to the client base Ask the right questions Get to the table in the rule making process (the big PBMs are already there) Offer solutions, but realize it will not be one size fits all

Once we get past the “bar talk,” there are some very real issues D E F I N I N G V A L U E Once we get past the “bar talk,” there are some very real issues Risk-assessment on the open market Marketing and cost control strategies Employer group markets and the trend towards defined contribution Specialty pharmacy Guarantee issue for the disabled

How does Medicare Part D fit with the PBM business model? D E F I N I N G V A L U E How does Medicare Part D fit with the PBM business model? Fit with core competencies – success will require a lot of attention, it cannot be an afterthought Focus on providing solutions that fit the needs of the specific client; this may mean focusing on certain business segments to be successful Bring staff in-house or form strategic alliances with organizations that provide specific expertise Medicare Part D PBM Business Model

The PBM needs to provide solutions that include D E F I N I N G V A L U E The PBM needs to provide solutions that include Pricing and cost management Plan design Marketing and communications Reporting Analysis Quick response is necessary as the market and your business changes